Top Buy
| Security | Buy | Sell | Buy (1M) ▲ | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Sarepta Therapeutics | 9 | 0 | 8 | 0 | €139.40 | €180.00 | 29.125% |
| Pfizer Inc. | 35 | 4 | 8 | 0 | €25.83 | €40.00 | 54.889% |
| Biogen Inc. | 58 | 1 | 8 | 0 | €210.80 | €291.35 | 38.209% |
| Intra-Cellular Therapies Inc. | 35 | 0 | 10 | 0 | €66.50 | €84.40 | 26.920% |
| Insmed Inc. | 39 | 1 | 10 | 1 | €64.50 | €70.13 | 8.721% |
| Amgen Inc. | 34 | 0 | 11 | 0 | €289.95 | €305.58 | 5.389% |
| Vertex Pharmaceuticals Inc. | 58 | 2 | 11 | 0 | €448.00 | €459.80 | 2.634% |
| Alnylam Pharmace. | 47 | 0 | 11 | 0 | €237.60 | €256.11 | 7.789% |
| Gilead Sciences Inc | 23 | 1 | 12 | 0 | €62.44 | €75.00 | 20.115% |
| Regeneron Pharmaceuticals Inc. | 51 | 1 | 14 | 0 | €967.40 | €1,049.8 | 8.514% |
| AbbVie Inc. | 42 | 0 | 20 | 0 | €154.16 | €176.14 | 14.258% |
| Eli Lilly Corp. | 79 | 0 | 30 | 0 | €854.90 | €900.00 | 5.275% |